Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholangiocarcinoma | 3 | 2022 | 34 | 1.630 |
Why?
|
| Bile Duct Neoplasms | 3 | 2022 | 58 | 1.590 |
Why?
|
| Isocitrate Dehydrogenase | 3 | 2024 | 26 | 1.210 |
Why?
|
| Neoplasms | 4 | 2025 | 1392 | 1.040 |
Why?
|
| Tumor Microenvironment | 4 | 2025 | 162 | 0.970 |
Why?
|
| Citric Acid Cycle | 1 | 2025 | 29 | 0.930 |
Why?
|
| Immune Evasion | 1 | 2024 | 68 | 0.820 |
Why?
|
| Dioxygenases | 2 | 2022 | 25 | 0.770 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2018 | 68 | 0.680 |
Why?
|
| Cell Polarity | 2 | 2018 | 109 | 0.590 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 9 | 0.590 |
Why?
|
| GTP Phosphohydrolases | 1 | 2018 | 64 | 0.560 |
Why?
|
| Immunity, Innate | 1 | 2024 | 803 | 0.560 |
Why?
|
| Stem Cells | 1 | 2018 | 262 | 0.510 |
Why?
|
| Neoplastic Stem Cells | 4 | 2015 | 199 | 0.500 |
Why?
|
| Bile Ducts, Intrahepatic | 3 | 2022 | 27 | 0.410 |
Why?
|
| Head and Neck Neoplasms | 2 | 2011 | 167 | 0.380 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2011 | 259 | 0.360 |
Why?
|
| Liver Neoplasms | 2 | 2025 | 306 | 0.340 |
Why?
|
| Mice | 10 | 2025 | 11003 | 0.330 |
Why?
|
| Heat-Shock Proteins | 1 | 2010 | 68 | 0.320 |
Why?
|
| Cell Line, Tumor | 6 | 2025 | 1494 | 0.320 |
Why?
|
| Mutation | 3 | 2024 | 2629 | 0.320 |
Why?
|
| Animals | 11 | 2025 | 20962 | 0.310 |
Why?
|
| Humans | 18 | 2025 | 64279 | 0.240 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2025 | 9 | 0.240 |
Why?
|
| MicroRNAs | 3 | 2018 | 697 | 0.230 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2025 | 5 | 0.230 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2025 | 5 | 0.230 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2025 | 9 | 0.230 |
Why?
|
| Epigenesis, Genetic | 3 | 2024 | 391 | 0.220 |
Why?
|
| Extracellular Vesicles | 1 | 2025 | 46 | 0.220 |
Why?
|
| DNA-Binding Proteins | 2 | 2022 | 1196 | 0.220 |
Why?
|
| DNA Methylation | 2 | 2024 | 294 | 0.220 |
Why?
|
| Glutarates | 1 | 2024 | 10 | 0.220 |
Why?
|
| DNA Demethylation | 1 | 2024 | 3 | 0.220 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2025 | 58 | 0.220 |
Why?
|
| Signal Transduction | 4 | 2025 | 3070 | 0.220 |
Why?
|
| Tumor Escape | 1 | 2024 | 16 | 0.210 |
Why?
|
| Thiadiazoles | 1 | 2023 | 5 | 0.210 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2023 | 3 | 0.210 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2023 | 13 | 0.210 |
Why?
|
| Naphthalenes | 1 | 2023 | 17 | 0.210 |
Why?
|
| Nucleotidyltransferases | 1 | 2024 | 63 | 0.200 |
Why?
|
| DNA Transposable Elements | 1 | 2024 | 139 | 0.200 |
Why?
|
| Proteomics | 1 | 2025 | 294 | 0.200 |
Why?
|
| Alkylating Agents | 1 | 2023 | 10 | 0.200 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2025 | 181 | 0.200 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2024 | 73 | 0.190 |
Why?
|
| CTLA-4 Antigen | 1 | 2022 | 73 | 0.180 |
Why?
|
| Biology | 1 | 2022 | 27 | 0.180 |
Why?
|
| RNA-Binding Proteins | 1 | 2025 | 443 | 0.180 |
Why?
|
| RNA | 1 | 2025 | 429 | 0.180 |
Why?
|
| Immunotherapy | 1 | 2023 | 265 | 0.170 |
Why?
|
| Cell Line | 2 | 2018 | 2055 | 0.170 |
Why?
|
| Mammary Glands, Animal | 1 | 2020 | 79 | 0.160 |
Why?
|
| Estrogens | 1 | 2020 | 116 | 0.160 |
Why?
|
| Interferon-gamma | 1 | 2022 | 576 | 0.160 |
Why?
|
| DNA | 1 | 2024 | 844 | 0.150 |
Why?
|
| Estradiol | 1 | 2020 | 258 | 0.150 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2018 | 34 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 329 | 0.140 |
Why?
|
| Transcription Factors | 2 | 2025 | 1540 | 0.140 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 1213 | 0.140 |
Why?
|
| Mice, Knockout | 2 | 2020 | 2140 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2020 | 1365 | 0.130 |
Why?
|
| Mitochondria | 1 | 2018 | 384 | 0.110 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 32 | 0.110 |
Why?
|
| Histocompatibility Antigens | 1 | 2015 | 105 | 0.110 |
Why?
|
| Leptin | 1 | 2015 | 87 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 72 | 0.110 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 63 | 0.110 |
Why?
|
| Obesity | 2 | 2023 | 1248 | 0.090 |
Why?
|
| Cell Movement | 2 | 2011 | 466 | 0.090 |
Why?
|
| src-Family Kinases | 1 | 2011 | 64 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 783 | 0.090 |
Why?
|
| Glycoproteins | 1 | 2011 | 189 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2011 | 348 | 0.080 |
Why?
|
| Mice, Nude | 1 | 2010 | 281 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2025 | 679 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 297 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2010 | 668 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 891 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 901 | 0.070 |
Why?
|
| Peptides | 1 | 2011 | 590 | 0.070 |
Why?
|
| RNA Interference | 1 | 2010 | 618 | 0.060 |
Why?
|
| Isotope Labeling | 1 | 2025 | 70 | 0.060 |
Why?
|
| Jurkat Cells | 1 | 2025 | 110 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 1 | 2025 | 129 | 0.060 |
Why?
|
| Female | 4 | 2020 | 33382 | 0.050 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2024 | 4 | 0.050 |
Why?
|
| Carnitine | 1 | 2024 | 20 | 0.050 |
Why?
|
| Glycolysis | 1 | 2024 | 57 | 0.050 |
Why?
|
| Carcinogenesis | 2 | 2015 | 131 | 0.050 |
Why?
|
| Arylsulfotransferase | 1 | 2023 | 1 | 0.050 |
Why?
|
| Sulfotransferases | 1 | 2023 | 8 | 0.050 |
Why?
|
| Interferons | 1 | 2023 | 73 | 0.050 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2022 | 5 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 205 | 0.050 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2023 | 87 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 219 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 201 | 0.050 |
Why?
|
| Immune System | 1 | 2023 | 131 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2015 | 534 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2022 | 120 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2022 | 146 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 189 | 0.040 |
Why?
|
| Endocrine System | 1 | 2020 | 17 | 0.040 |
Why?
|
| Estrogen Receptor alpha | 1 | 2020 | 49 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2020 | 273 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1001 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 2238 | 0.030 |
Why?
|
| Receptors, Leptin | 1 | 2015 | 13 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 67 | 0.030 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2015 | 29 | 0.030 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2014 | 6 | 0.030 |
Why?
|
| Transcription Factor HES-1 | 1 | 2014 | 7 | 0.030 |
Why?
|
| Receptor, Notch2 | 1 | 2014 | 8 | 0.030 |
Why?
|
| Jagged-1 Protein | 1 | 2014 | 8 | 0.030 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2014 | 8 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 34 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 48 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 93 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 153 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 272 | 0.020 |
Why?
|
| AC133 Antigen | 1 | 2011 | 6 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2011 | 27 | 0.020 |
Why?
|
| Clone Cells | 1 | 2011 | 116 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 2005 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 279 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 319 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 207 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 948 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2014 | 909 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 1187 | 0.020 |
Why?
|
| Apoptosis | 1 | 2011 | 1094 | 0.020 |
Why?
|